Search research articles
Contact Us
Filters
Showing results (311-320 of 364) with videos related to
Page
of 37
Sort By:
Plos Pathogens
|
February 3, 2025
GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18
Andrew S Wagner, Frances M Smith, David A Bennin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 6, 2004
PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle
Li Fang, Yibing Yan, Laszlo G Komuves, et al.
Oncotarget
|
April 8, 2015
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
Yiyao Zhang, Li Liu, Pei Fan, et al.
Frontiers in Immunology
|
August 25, 2025
Single cell autofluorescence imaging reveals immediate metabolic shifts of neutrophils with activation across biological systems
Rupsa Datta, Veronika Miskolci, Gina M Gallego-López, et al.
Molecular Cancer
|
April 27, 2010
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
Mert Erkan, Nadine Weis, Zheng Pan, et al.
Journal of Medicinal Chemistry
|
August 9, 2002
Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family
Anjali Pandey, Deborah L Volkots, Joseph M Seroogy, et al.
JCI Insight
|
December 12, 2022
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
Kilian B Kennel, Julius Burmeister, Praveen Radhakrishnan, et al.
Plos One
|
November 16, 2012
Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system
Johannes Fredebohm, Michael Boettcher, Christian Eisen, et al.
Oncotarget
|
March 17, 2018
Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer
Verena M Throm, David Männle, Thomas Giese, et al.
Annals of Neurology
|
September 8, 2000
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants
I Zerr, W J Schulz-Schaeffer, A Giese, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 364) with videos related to
Sort By:
Page
of 37
Plos Pathogens
|
February 3, 2025
GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18
Andrew S Wagner, Frances M Smith, David A Bennin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 6, 2004
PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle
Li Fang, Yibing Yan, Laszlo G Komuves, et al.
Oncotarget
|
April 8, 2015
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
Yiyao Zhang, Li Liu, Pei Fan, et al.
Frontiers in Immunology
|
August 25, 2025
Single cell autofluorescence imaging reveals immediate metabolic shifts of neutrophils with activation across biological systems
Rupsa Datta, Veronika Miskolci, Gina M Gallego-López, et al.
Molecular Cancer
|
April 27, 2010
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
Mert Erkan, Nadine Weis, Zheng Pan, et al.
Journal of Medicinal Chemistry
|
August 9, 2002
Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family
Anjali Pandey, Deborah L Volkots, Joseph M Seroogy, et al.
JCI Insight
|
December 12, 2022
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
Kilian B Kennel, Julius Burmeister, Praveen Radhakrishnan, et al.
Plos One
|
November 16, 2012
Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system
Johannes Fredebohm, Michael Boettcher, Christian Eisen, et al.
Oncotarget
|
March 17, 2018
Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer
Verena M Throm, David Männle, Thomas Giese, et al.
Annals of Neurology
|
September 8, 2000
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants
I Zerr, W J Schulz-Schaeffer, A Giese, et al.
Page
of 37